Aarti Drugs shares rallied over 10.88% in Monday's trading session defying weak sentiments in the Indian stock market. The pharma stock opened at ₹457 apiece on the BSE and surged to an intraday high of ₹513, registering strong buying interest during the session.
Meanwhile, the broader market remained under pressure. The Sensex and Nifty traded lower as investors booked profits following a sharp seven-session rally through Friday, during which benchmark indices gained around 10.5%. The Sensex was down around 0.2% in early trade, while the Nifty 50 slipped below the 25,000 mark. Against this backdrop, Aarti Drugs shares emerged as a notable outperformer.
The stock rally came in after Aarti Drugs shares witnessed a spurt in its trading volume. According to data available on NSE, around 348.19 lakh shares changed hands during the intraday session on Monday.
Aarti Drugs reported a strong set of financial results for the September quarter of FY27, with consolidated net profit rising 83% YoY to ₹82.8 crore, compared with ₹45.2 crore in the corresponding quarter last year.
The company's consolidated revenue increased 27% YoY to ₹828.8 crore from ₹652.9 crore in Q2 FY26. Earnings before interest, taxes, depreciation and amortisation (EBITDA) jumped 63% to ₹137.9 crore against ₹84.4 crore in the year-ago quarter.